Gossamer Bio

Gossamer

The company develops seralutinib for patients with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

Respira

This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.

Avalyn Pharma

The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.

Liquidia Technologies

This biopharmaceutical company develops inhaled therapies for patients with pulmonary arterial hypertension and other cardiopulmonary diseases using a proprietary particle engineering platform.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

Kither Biotech

This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.

Savara

This biopharmaceutical company develops inhaled therapies for patients with rare respiratory diseases, such as autoimmune pulmonary alveolar proteinosis.

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.